Federal law allows a sibling to sign over their half of a jointly owned home to another sibling without Medicaid's five-year look-back penalty, provided the sibling receiving the home has lived there as their primary residence for at least one year before the other sibling enters a nursing home. This exception protects the home from Medicaid liens and penalties, but it requires that the home is the transferor's primary residence and that the transfer is properly documented with a gift tax return. If the older sibling does not live in the home, the exemption does not apply, and the transfer could trigger costly Medicaid penalties. Families should consult elder law attorneys to navigate state-specific rules and ensure compliance.
The story about two sisters jointly owning their mother's house provides context for readers interested in property and family asset management. For readers following the Financials sector, here is Pluang's market snapshot as of Oct 22, 2026 20:12 WIB: Of 142 priced Financials-sector US stocks tradable on Pluang, 30 rose and 110 fell today. Notable movers include AVAT at USD 1.27 with a 1-day change of -6.27% and a typical hold time of 13 days, GLXY at USD 15.99 down 5.55% with a 4-day hold time, and BMNR at USD 22.66 down 5.43% with a 2-day hold time. Pluang order activity shows AVAT heavily sold at 90% Sell / 10% Buy.
Dayton T. Brown, Inc. inaugurated its new 104,000-square-foot Test & Qualification Center in Huntsville, Alabama, enhancing its capacity to support aerospace, defense, and propulsion programs. The facility's strategic location near Huntsville's aeros...
A new study by The Grossman Group reveals that while 60% of chief communications officers (CCOs) have influence at the leadership level, their communications functions lack the necessary systems, skills, and AI capabilities to fully meet their mandat...
More than 200 companies are actively developing over 240 Alzheimer's disease therapies, with around 20 drugs in late-stage trials and many others in earlier phases. Key players include Eli Lilly, Biogen, Johnson & Johnson, and Eisai, focusing on inno...
Sagimet Biosciences has initiated a crucial Phase 3 clinical trial in the U.S. for denifanstat, an oral treatment targeting moderate to severe acne. The trial, named AURORA, aims to enroll around 800 patients, including adolescents, to support regula...
Nokia reported third-quarter 2026 earnings per share of $0.10, surpassing the $0.08 estimate, and revenue of $5.78 billion, exceeding the $5.72 billion forecast. The company's AI and cloud sales surged 123%, driven by high demand for its IP Networks ...
